H.R.2592 - Aviation Medication Transparency Act of 2025 (119th Congress)
Summary
H.R. 2592, the Aviation Medication Transparency Act of 2025, mandates the Federal Aviation Administration (FAA) to publish and maintain a publicly accessible list of medications approved for airmen. This list is intended to provide transparency regarding medical certifications. The bill requires the FAA to consult with various stakeholders, including air traffic controller representatives and pilot organizations, in drafting and updating the list annually.
Expected Effects
The Act will likely increase transparency and predictability in the FAA's medical certification process for airmen. This could lead to fewer delays and uncertainties for pilots and air traffic controllers regarding their medical fitness to fly. The FAA will be required to create a mechanism for medical providers to contact them with questions.
Potential Benefits
- Increased transparency in the FAA's medical certification process.
- Improved access to information for airmen regarding approved medications.
- Enhanced communication between the FAA and medical providers.
- Greater predictability for airmen regarding medical fitness and duty limitations.
- Potential for reduced delays in the medical certification process.
Potential Disadvantages
- Potential administrative burden on the FAA to compile, maintain, and update the list.
- Possible delays in implementation due to the consultation requirements.
- Risk of the list becoming outdated if not updated frequently enough.
- Potential for misinterpretation of the list by airmen or medical providers without proper context.
- Possible legal challenges if the list is perceived as discriminatory or arbitrary.
Constitutional Alignment
The bill appears to align with the general welfare clause of the US Constitution, as it aims to improve the health and safety of air travel. Specifically, the Act does not appear to infringe upon any specific rights enumerated in the Constitution or its amendments. The legislative power to regulate interstate commerce, as outlined in Article I, Section 8, Clause 3, provides a basis for congressional action related to aviation safety and regulation.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).